Aberrant histone acetylation, altered transcription, and retinal degeneration in a <i>Drosophila</i> model of polyglutamine disease are rescued by CREB-binding protein

J. Paul Taylor(National Institute of Neurological Disorders and Stroke), Addis A. Taye(National Institutes of Health), Catherine E. Campbell(National Institutes of Health), Parsa Kazemi‐Esfarjani(University at Buffalo, State University of New York), Kenneth H. Fischbeck(National Institutes of Health), Kyung‐Tai Min(National Institutes of Health)
Genes & Development
June 15, 2003
Cited by 137Open Access
Full Text

Abstract

Sequestration of the transcriptional coactivator CREB-binding protein (CBP), a histone acetyltransferase, has been implicated in the pathogenesis of polyglutamine expansion neurodegenerative disease. We used a Drosophila model to demonstrate that polyglutamine-induced neurodegeneration is accompanied by a defect in histone acetylation and a substantial alteration in the transcription profile. Furthermore, we demonstrate complete functional and morphological rescue by up-regulation of endogenous Drosophila CBP (dCBP). Rescue of the degenerative phenotype is associated with eradication of polyglutamine aggregates, recovery of histone acetylation, and normalization of the transcription profile. These findings suggest that histone acetylation is an early target of polyglutamine toxicity and indicate that transcriptional dysregulation is an important part of the pathogenesis of polyglutamine-induced neurodegeneration.


Related Papers

No related papers found

Powered by citation graph analysis